NCT05844241

Brief Summary

The greying of the world is leading to a rapid acceleration in both the healthcare costs and caregiver burden that are associated with dementia. There is an urgent need to develop new, easily scalable modalities of support to reduce agitation and anxiety in those with dementia. There is evidence that music interventions reduce agitation and anxiety in those with dementia. LUCID has developed a novel digital music therapeutic product that uses a reinforcement learning AI agent to curate and personalize the musical playlist while incorporating binaural theta auditory beat stimulation (ABS) to reduce anxiety and agitation in those with dementia. This study will be conducted remotely with study hardware (tablets and Bluetooth speakers) being shipped to caregivers/participants' homes. The study will take place over a 2-week period, with participants completing 4 one-hour sessions per week along with an additional 1-hour follow-up interview session. Forty-eight participants with mild to moderate dementia (as defined by the Montreal Cognitive Assessment) will be evenly randomized to one of two conditions. The control condition consists of a selection of 30-minute audiobooks which the participant has the freedom to select from. The experimental condition consists of music and binaural ABS curated by LUCID's AI system. Participants' caregivers will complete baseline questionnaires assessing the participants' anxiety, agitation, and mood. They will also complete these questionnaires before and after each experimental session. The investigators hypothesize that the LUCID AI music curation system will have a greater agitation and anxiety reduction compared to the audiobook control condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

May 8, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 3, 2023

Completed
Last Updated

November 22, 2023

Status Verified

May 1, 2023

Enrollment Period

3 months

First QC Date

April 10, 2023

Last Update Submit

November 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cohen Mansfield Agitation Index

    The purpose of this scale is to assess the frequency of manifestations of agitated behaviors in elderly persons. Minimum score: 14, Maximum score: 70. Higher score indicates a worse outcome (increased agitation).

    2 weeks

Secondary Outcomes (6)

  • Rating of Anxiety in Dementia

    2 weeks

  • Cornell Brown Scale for Quality of Life in Dementia

    2 weeks

  • Zarit Caregiver Burden Interview

    2 weeks

  • Positive and Negative Affect Scale

    30 minutes

  • Overt Agitation Severity Scale

    30 minutes

  • +1 more secondary outcomes

Study Arms (2)

Music and Theta Auditory Beat Stimulation (ABS)

EXPERIMENTAL

Participants listen to 30 minutes of personalized music with theta auditory beat stimulation (ABS).

Other: Music and Theta Auditory Beat Stimulation

Audiobooks

ACTIVE COMPARATOR

Participants listen to a 30-minute audiobook.

Other: Audiobooks

Interventions

Listening to music and ABS for 30 minutes.

Music and Theta Auditory Beat Stimulation (ABS)

Listening to audiobooks for 30 minutes

Audiobooks

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Mild to Moderate Dementia (mild: Montreal Cognitive Assessment (MOCA) scores (18-25); moderate: MOCA scores (10-17)))

You may not qualify if:

  • Unmanaged hearing loss (defined as average pure-tone average threshold of 35 dB HL or greater without the use of hearing instruments or personal sound amplification product)
  • Severe Tinnitus
  • Hyperacusis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LUCID Therapeutics

Toronto, Ontario, M5C 1K9, Canada

Location

MeSH Terms

Interventions

Sound Recordings

Intervention Hierarchy (Ancestors)

Audiovisual AidsEducational TechnologyTechnologyTechnology, Industry, and Agriculture

Study Officials

  • Adiel Mallik, PhD

    Lucid, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2023

First Posted

May 6, 2023

Study Start

May 8, 2023

Primary Completion

August 2, 2023

Study Completion

August 3, 2023

Last Updated

November 22, 2023

Record last verified: 2023-05

Locations